{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:03:11Z","timestamp":1791568991054,"version":"4.3.4"},"reference-count":54,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of North Carolina Greensboro"},{"name":"Phi Kappa Phi Honor Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Immune checkpoint inhibitors (ICIs) are a new anti-cancer therapy that have improved survival rates in many aggressive cancers. However, while rare, a significant number of patients develop ICI-induced cardiotoxicity. Clinical manifestations are non-specific and underlying cellular mechanisms remain unknown, making diagnosis and treatment of these ICI-induced cardiac side effects difficult. Exercise has shown protective effects against chemotherapy-induced cardiotoxicity but has not been investigated in combination with ICIs. High-intensity exercise has shown greatest cardioprotective effects in preclinical (animal) models, but human cancer patients prefer low-intensity exercise in the clinical setting. Therefore, the purpose of this study was to further identify the cardioprotective effects of low-intensity exercise as a treatment strategy against ICI-induced cardiotoxicity. Methods: Female mice were randomly selected and separated into four groups: sedentary (SED), sedentary ICI-treated (SED + ICI), low-intensity treadmill-exercised (TM), and low-intensity treadmill-exercised ICI-treated mice (TM + ICI). Mice either underwent a 4-week low-intensity treadmill exercise protocol (TM) or remained sedentary (SED). During the 4 weeks, ICI mice received anti-PD-1 treatment (200 \u03bcg\/mouse) via intraperitoneal injections twice each week. Echocardiography was performed at baseline and sacrifice to determine changes in cardiac structure and function. At sacrifice, cardiac tissue was collected, weighed, and frozen for further biochemical analysis. Underlying metabolic signaling pathways were assessed via Western Blot, and autophagic flux was analyzed via fluorescent microscopy. Results: Echocardiography at sacrifice revealed significantly decreased fractional shortening as a measure of cardiac function (\u221220%), 1.5-fold dilation of the left ventricle, and thinning of the posterior cardiac wall at systole and diastole in SED + ICI mice compared to SED controls (p &lt; 0.05), indicative of a phenotype of ICI-induced dilated cardiomyopathy. TM + ICI mice did not show a significant difference in these cardiac structural and functional parameters, suggesting cardioprotective effects of low-intensity exercise. In line with these findings, Western Blot and fluorescent microscopy analyses revealed upregulation of autophagic flux (p &lt; 0.05), as well as dysfunctional metabolic pathways (p &lt; 0.05) in ICI-treated mice compared to non-ICI controls. Low-intensity exercise was associated with regulation of dysfunctional metabolism and autophagy in TM + ICI compared to SED + ICI mice. Conclusions: The clinically relevant ICI treatment protocol used in this study led to significant cardiac dysfunction and remodeling, accompanied by underlying dysfunctional metabolism and autophagy. Low-intensity exercise was capable of regulating abnormal protein synthesis and degradation and protecting against ICI-induced cardiotoxicity. This study adds knowledge to the characterization of still unclear clinical manifestations of ICI-induced cardiotoxicity, underlying signaling pathways that could shed light on potential pharmacological treatment targets, as well as the protective effects of low-intensity exercise as a non-pharmacological treatment strategy.<\/jats:p>","DOI":"10.3390\/cancers18010138","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:08:11Z","timestamp":1767190091000},"page":"138","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Low-Intensity Exercise Attenuates Immune Checkpoint Inhibitor-Induced Cardiotoxicity via Regulation of Metabolism and Autophagy"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-9139","authenticated-orcid":false,"given":"Louisa","family":"Tichy","sequence":"first","affiliation":[{"name":"Kinesiology Department, University of North Carolina Greensboro, 1408 Walker Ave., Greensboro, NC 27412, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-4537","authenticated-orcid":false,"given":"Traci L.","family":"Parry","sequence":"additional","affiliation":[{"name":"Kinesiology Department, University of North Carolina Greensboro, 1408 Walker Ave., Greensboro, NC 27412, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"ref_1","unstructured":"McCluskey, K. (2022, October 17). Immunotherapy vs. Chemotherapy: What\u2019s the Difference? Cancer Research Institute. Available online: https:\/\/www.cancerresearch.org\/blog\/difference-cancer-immunotherapy-and-chemotherapy."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1200\/JCO.19.00934","article-title":"Five-Year Overall Survival for Patients with Advanced Non\u2013Small-Cell Lung Cancer Treated with Pembrolizumab: Results from the Phase I KEYNOTE-001 Study","volume":"37","author":"Garon","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Li, C., Bhatti, S.A., and Ying, J. (2022). Immune Checkpoint Inhibitors\u2014Associated Cardiotoxicity. Cancers, 14.","DOI":"10.3390\/cancers14051145"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bph.15984","article-title":"Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment","volume":"180","author":"Gergely","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1249\/MSS.0000000000001544","article-title":"Exercise Protects Against Cancer-Induced Cardiac Cachexia","volume":"50","author":"Parry","year":"2018","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2022.05.006","article-title":"Exercise-induced engagement of the IL-15\/IL-15R\u03b1 axis promotes anti-tumor immunity in pancreatic cancer","volume":"40","author":"Kurz","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_7","first-page":"100","article-title":"Benefits of exercise and immunotherapy in a murine model of human non\u2013small-cell lung carcinoma","volume":"26","author":"Coronado","year":"2020","journal-title":"Exerc. Immunol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Allan, J., Buss, L.A., Draper, N., and Currie, M.J. (2022). Exercise in People with Cancer: A Spotlight on Energy Regulation and Cachexia. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.836804"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Parry, T.L., Tichy, L., and Brantley, J.T. (2022). Cardioprotective effects of preconditioning exercise in the female tumor bearing mouse. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.950479"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17706","DOI":"10.1002\/cam4.6388","article-title":"The pathophysiology of cancer-mediated cardiac cachexia and novel treatment strategies: A narrative review","volume":"12","author":"Tichy","year":"2023","journal-title":"Cancer Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e59996","DOI":"10.7554\/eLife.59996","article-title":"Cytotoxic T-cells mediate exercise-induced reductions in tumor growth","volume":"9","author":"Rundqvist","year":"2020","journal-title":"eLife"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaccao.2025.05.003","article-title":"Lung Cancer and Cardiovascular Disease","volume":"7","author":"Yu","year":"2025","journal-title":"JACC CardioOncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.hlc.2023.06.854","article-title":"A Clinical Guide for Assessment and Prescription of Exercise and Physical Activity in Cardiac Rehabilitation. A CSANZ Position Statement","volume":"32","author":"Verdicchio","year":"2023","journal-title":"Heart Lung Circ."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/pon.4512","article-title":"Patients with established cancer cachexia lack the motivation and self-efficacy to undertake regular structured exercise","volume":"27","author":"Wasley","year":"2018","journal-title":"Psychooncology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jamaoncol.2020.2045","article-title":"Association of Sedentary Behavior with Cancer Mortality in Middle-aged and Older US Adults","volume":"6","author":"Gilchrist","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ygyno.2015.05.026","article-title":"Physical Activity and Sedentary Behavior in Breast Cancer Survivors: New Insight into Activity Patterns and Potential Intervention Targets","volume":"138","author":"Phillips","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/1878-0261.12772","article-title":"Physical activity, obesity and sedentary behavior in cancer etiology: Epidemiologic evidence and biologic mechanisms","volume":"15","author":"Friedenreich","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1152\/japplphysiol.00148.2005","article-title":"Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity","volume":"100","author":"Chicco","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gomes-Santos, I.L., Jord\u00e3o, C.P., Passos, C.S., Brum, P.C., Oliveira, E.M., Chammas, R., Camargo, A.A., and Negr\u00e3o, C.E. (2021). Exercise Training Preserves Myocardial Strain and Improves Exercise Tolerance in Doxorubicin-Induced Cardiotoxicity. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.605993"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1258\/ebm.2012.012137","article-title":"Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity","volume":"237","author":"Hydock","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40959-022-00130-5","article-title":"Cardiotoxicity risk factors with immune checkpoint inhibitors","volume":"8","author":"Brumberger","year":"2022","journal-title":"Cardio-Oncology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIR.0000000000001158","article-title":"Equity in Cardio-Oncology Care and Research: A Scientific Statement from the American Heart Association","volume":"148","author":"Addison","year":"2023","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41569-022-00807-5","article-title":"Hormone therapy ameliorates ICI-related myocarditis in mice","volume":"20","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/mab.2021.0068","article-title":"A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies","volume":"41","author":"Bu","year":"2022","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/2326-6066.CIR-22-0465","article-title":"Aerobic Exercise Alters the Melanoma Microenvironment and Modulates ERK5 S496 Phosphorylation","volume":"11","author":"Savage","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCULATIONAHA.122.062814","article-title":"Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study","volume":"147","author":"Foulkes","year":"2023","journal-title":"Circulation"},{"key":"ref_27","first-page":"9","article-title":"The Bradford method for protein quantitation","volume":"32","author":"Kruger","year":"1994","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/HCO.0b013e328345980a","article-title":"Tuning flux: Autophagy as a target of heart disease therapy","volume":"26","author":"Xie","year":"2011","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature12639","article-title":"Functional interaction between autophagy and ciliogenesis","volume":"502","author":"Pampliega","year":"2013","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13063-019-3499-9","article-title":"Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: A study protocol for a randomized controlled trial","volume":"20","author":"Antunes","year":"2019","journal-title":"Trials"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1096\/fj.201801862R","article-title":"Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations","volume":"33","author":"Pin","year":"2019","journal-title":"FASEB J."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Balboa, E., Gonz\u00e1lez-Salvado, V., Rodr\u00edguez-Romero, B., Mart\u00ednez-Monzon\u00eds, A., Pedreira-P\u00e9rez, M., Palacios-Ozores, P., L\u00f3pez-L\u00f3pez, R., Pe\u00f1a-Gil, C., and Gonz\u00e1lez-Juanatey, J.R. (2021). A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-021-01970-2"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Schneider, C., Ryffel, C., Rabaglio, M., Suter, T.M., Campbell, K.L., Eser, P., and Wilhelm, M. (2023). Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity\u2014A randomized controlled trial. medRxiv, 2023.02.06.23285559.","DOI":"10.1101\/2023.02.06.23285559"},{"key":"ref_34","first-page":"79","article-title":"Patterns and influencing factors of exercise attendance of breast cancer patients during neoadjuvant chemotherapy","volume":"32","author":"Goldschmidt","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Avancini, A., Pala, V., Trestini, I., Tregnago, D., Mariani, L., Sieri, S., Krogh, V., Boresta, M., Milella, M., and Pilotto, S. (2020). Exercise Levels and Preferences in Cancer Patients: A Cross-Sectional Study. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17155351"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1002\/rco2.103","article-title":"Low-Intensity Exercise Protects Skeletal and Cardiac Muscle Against Cancer-Mediated Muscle Wasting via Regulation of Autophagy and Inflammation","volume":"8","author":"Tichy","year":"2025","journal-title":"JCSM Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e021580","DOI":"10.1161\/JAHA.121.021580","article-title":"Efficacy of Physical Exercise to Offset Anthracycline-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis of Clinical and Preclinical Studies","volume":"10","author":"Naaktgeboren","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1002\/cam4.4283","article-title":"Exercise intervention decreases acute and late doxorubicin-induced cardiotoxicity","volume":"10","author":"Wang","year":"2021","journal-title":"Cancer Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kang, D.-W., Wilson, R.L., Christopher, C.N., Normann, A.J., Barnes, O., Lesansee, J.D., Choi, G., and Dieli-Conwright, C.M. (2022). Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.805735"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gaytan, S.L., Lawan, A., Chang, J., Nurunnabi, M., Bajpeyi, S., Boyle, J.B., Han, S.M., and Min, K. (2023). The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1133423"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1074\/jbc.RA119.011571","article-title":"Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2\u2013mediated activation of forkhead box O1","volume":"295","author":"Xia","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-07-0397","article-title":"Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells","volume":"7","author":"Hui","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1074\/jbc.M111.284224","article-title":"Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin","volume":"287","author":"Ho","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kwon, I., Go, G.-W., Lee, Y., and Kim, J.-H. (2022). Prolonged Endurance Exercise Adaptations Counteract Doxorubicin Chemotherapy-Induced Myotoxicity in Mice. Appl. Sci., 12.","DOI":"10.3390\/app12073652"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1152\/japplphysiol.00210.2014","article-title":"Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle","volume":"117","author":"Kavazis","year":"2014","journal-title":"J. Appl. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"H1470","DOI":"10.1152\/ajpheart.00838.2020","article-title":"FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K","volume":"320","author":"Weeks","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1101\/gad.1492806","article-title":"Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway","volume":"20","author":"Shiojima","year":"2006","journal-title":"Genes Dev."},{"key":"ref_48","unstructured":"Xiao, J. (2017). The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection. Exercise for Cardiovascular Disease Prevention and Treatment: From Molecular to Clinical, Part 2, Springer."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"47622","DOI":"10.1074\/jbc.M305909200","article-title":"Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt","volume":"48","author":"Kim","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-0034-1395585","article-title":"Regulation of mTOR Pathway in Exercise-induced Cardiac Hypertrophy","volume":"36","author":"Liao","year":"2015","journal-title":"Int. J. Sports Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bbamcr.2008.12.011","article-title":"Autophagy in the cardiovascular system","volume":"1793","author":"Martinet","year":"2009","journal-title":"Biochim. Biophys. Acta BBA\u2014Mol. Cell Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jshs.2019.10.001","article-title":"Exercise-mediated regulation of autophagy in the cardiovascular system","volume":"9","author":"Wang","year":"2020","journal-title":"J. Sport Health Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1002\/ehf2.13065","article-title":"The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy","volume":"7","author":"Yu","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.tem.2019.07.009","article-title":"The FoxO\u2013Autophagy Axis in Health and Disease","volume":"30","author":"Cheng","year":"2019","journal-title":"Trends Endocrinol. Metab."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/1\/138\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:15:27Z","timestamp":1767190527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/1\/138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["cancers18010138"],"URL":"https:\/\/doi.org\/10.3390\/cancers18010138","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}